telmisartan has been researched along with Acute Confusional Senile Dementia in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (11.11) | 29.6817 |
| 2010's | 10 (55.56) | 24.3611 |
| 2020's | 6 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Dai, F; Hu, H; Li, X; Lv, Z; Ren, J; Wang, J; Zhang, B | 1 |
| Campbell, N; Cheng, F; Cummings, J; Gao, S; Hou, Y; Leverenz, JB; Pieper, AA; Tu, W; Zhang, P | 1 |
| Cao, HM; Deng, Y; Duan, R; Fu, XX; Jiang, T; Lian, HW; Wei, B; Zhang, YD | 1 |
| Ihara, M; Saito, S | 1 |
| Abd El-Latif, AM; Abdelkader, NF; Khattab, MM | 1 |
| Abo-Youssef, AM; Khallaf, WA; Khattab, MM; Messiha, BAS | 1 |
| Asraf, K; Cohen, H; Fleisher-Berkovich, S; Torika, N | 1 |
| Brown, AL; Cintron, A; Goldstein, FC; Kehoe, PG; Tansey, MG; Tharwani, SD; Verble, DD; Wharton, W | 1 |
| Abdelsalam, RM; Khalifa, M; Safar, MM; Zaki, HF | 1 |
| Kurinami, H; Morishita, R; Nakagami, H; Sato, N; Shimamura, M | 1 |
| Cheng, H; Jiang, L; Shang, Y; Shi, TL; Wang, L | 1 |
| Apte, RN; Asraf, K; Danon, A; Fleisher-Berkovich, S; Torika, N | 1 |
| Akai, T; Hanyu, H; Iwamoto, T; Sakurai, H; Sato, T; Takasaki, A | 1 |
| Horiuchi, M; Iwai, M; Iwanami, J; Jing, F; Min, LJ; Mogi, M; Sakata, A; Tsukuda, K | 1 |
| Hanyu, H; Iwamoto, T; Kume, K; Onuma, T; Sakurai, H; Takada, Y | 1 |
| Jaggi, AS; Sharma, B; Singh, B; Singh, N | 1 |
| Fujiwara, M; Irie, K; Iwasaki, K; Katsurabayashi, S; Kubota, K; Mishima, K; Nishimura, R; Onimura, R; Shindo, T; Takasaki, K; Uchida, K; Uchida, N | 1 |
| Bai, YY; Li, W; Liu, HQ; Lu, F; Ma, MM; Suo, AQ; Wang, JQ; Zhang, JW | 1 |
2 review(s) available for telmisartan and Acute Confusional Senile Dementia
| Article | Year |
|---|---|
Do angiotensin receptor blockers protect against Alzheimer's disease?
Topics: Aging; Alzheimer Disease; Amyloid beta-Peptides; Angiotensin Receptor Antagonists; Animals; Benzimidazoles; Benzoates; Cerebrovascular Circulation; Clinical Trials as Topic; Cognition; Disease Progression; Humans; Oxidative Stress; Phosphorylation; Telmisartan | 2013 |
The peroxisome proliferators activated receptor-gamma agonists as therapeutics for the treatment of Alzheimer's disease and mild-to-moderate Alzheimer's disease: a meta-analysis.
Topics: Alzheimer Disease; Benzimidazoles; Benzoates; Humans; Pioglitazone; PPAR gamma; Rosiglitazone; Telmisartan; Thiazolidinediones | 2016 |
3 trial(s) available for telmisartan and Acute Confusional Senile Dementia
| Article | Year |
|---|---|
Rationale and Design of the Mechanistic Potential of Antihypertensives in Preclinical Alzheimer's (HEART) Trial.
Topics: Aged; Alzheimer Disease; Amyloid beta-Peptides; Antihypertensive Agents; Biomarkers; Black or African American; Blood Pressure; Brain; Clinical Trials, Phase I as Topic; Female; Georgia; Humans; Linear Models; Male; Middle Aged; Randomized Controlled Trials as Topic; Renin-Angiotensin System; Telmisartan | 2018 |
Effects of telmisartan on cognition and regional cerebral blood flow in hypertensive patients with Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Brain; Cerebrovascular Circulation; Cognition; Female; Humans; Hypertension; Male; Prospective Studies; Regional Blood Flow; Single-Blind Method; Telmisartan | 2012 |
[Effects of telmisartan on the level of Aβ1-42, interleukin-1β, tumor necrosis factor α and cognition in hypertensive patients with Alzheimer's disease].
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amlodipine; Amyloid beta-Peptides; Antihypertensive Agents; Benzimidazoles; Benzoates; Cognition; Female; Humans; Hypertension; Interleukin-1beta; Male; Middle Aged; Peptide Fragments; PPAR gamma; Telmisartan; Tumor Necrosis Factor-alpha | 2012 |
13 other study(ies) available for telmisartan and Acute Confusional Senile Dementia
| Article | Year |
|---|---|
Hydrophilic polymer driven crystallization self-assembly: an inflammatory multi-drug combination nanosystem against Alzheimer's disease.
Topics: Alzheimer Disease; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antihypertensive Agents; Celecoxib; Cell Line; Crystallization; Drug Design; Humans; Ibuprofen; Male; Mice; Micelles; Molecular Structure; Nanostructures; Neuroinflammatory Diseases; Polymers; Telmisartan | 2021 |
Population-based discovery and Mendelian randomization analysis identify telmisartan as a candidate medicine for Alzheimer's disease in African Americans.
Topics: Alzheimer Disease; Black or African American; Diabetes Mellitus; Genome-Wide Association Study; Humans; Hypertension; Mendelian Randomization Analysis; Middle Aged; Telmisartan | 2023 |
Telmisartan Alleviates Alzheimer's Disease-Related Neuropathologies and Cognitive Impairments.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Anti-Inflammatory Agents; Cognitive Dysfunction; Disease Models, Animal; Mice; Mice, Transgenic; Neuroinflammatory Diseases; Telmisartan | 2023 |
[Drug Repositioning for Alzheimer's Disease].
Topics: Alzheimer Disease; Cilostazol; Dabigatran; Drug Repositioning; Humans; Insulin; Probucol; Telmisartan | 2019 |
Telmisartan/17β-estradiol mitigated cognitive deficit in an ovariectomized rat model of Alzheimer's disease: Modulation of ACE1/ACE2 and AT1/AT2 ratio.
Topics: Alzheimer Disease; Animals; Blotting, Western; Cognitive Dysfunction; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Estradiol; Female; Hippocampus; Maze Learning; Nootropic Agents; Ovariectomy; Rats; Rats, Wistar; Renin-Angiotensin System; Telmisartan | 2020 |
The anti-Alzheimer effect of telmisartan in a hyperglycemic ovariectomized rat model; role of central angiotensin and estrogen receptors.
Topics: Alzheimer Disease; Angiotensin II Type 1 Receptor Blockers; Angiotensins; Animals; Blood-Brain Barrier; Female; Hyperglycemia; Models, Animal; Ovariectomy; Rats; Rats, Wistar; Receptors, Estrogen; Telmisartan | 2020 |
Intranasal telmisartan ameliorates brain pathology in five familial Alzheimer's disease mice.
Topics: Administration, Intranasal; Alzheimer Disease; Amyloid beta-Peptides; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Cell Polarity; Cerebral Cortex; Disease Models, Animal; Encephalitis; Female; Gliosis; Humans; Male; Mice; Mice, Transgenic; Microglia; Spatial Processing; Telmisartan | 2017 |
Telmisartan Protects Against Aluminum-Induced Alzheimer-like Pathological Changes in Rats.
Topics: Aluminum; Alzheimer Disease; Amyloid beta-Peptides; Animals; Male; Maze Learning; Neuroprotective Agents; Rats; Rats, Wistar; Telmisartan | 2020 |
Telmisartan Modulates Glial Activation: In Vitro and In Vivo Studies.
Topics: Administration, Intranasal; Alzheimer Disease; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Cell Line; Cells, Cultured; Female; Male; Mice; Mice, Transgenic; Microglia; Neuroglia; Nitric Oxide; Rats; Rats, Wistar; Renin-Angiotensin System; Telmisartan | 2016 |
[A patient with early Alzheimer's disease who showed improvement of cognitive function and cerebral perfusion by combined therapy of nilvadipine and PPAR gamma agonists].
Topics: Aged; Alzheimer Disease; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Calcium Channel Blockers; Cerebrovascular Circulation; Cognition; Humans; Male; Nifedipine; PPAR gamma; Telmisartan | 2008 |
Cognitive deficit in amyloid-beta-injected mice was improved by pretreatment with a low dose of telmisartan partly because of peroxisome proliferator-activated receptor-gamma activation.
Topics: Administration, Oral; Alzheimer Disease; Amyloid beta-Peptides; Angiotensin II Type 1 Receptor Blockers; Anilides; Animals; Benzimidazoles; Benzoates; Cerebellum; Cognition Disorders; Disease Models, Animal; Dose-Response Relationship, Drug; Injections, Intraventricular; Male; Maze Learning; Mice; Mice, Inbred Strains; Nitric Oxide Synthase Type II; PPAR gamma; Regional Blood Flow; Telmisartan; Tumor Necrosis Factor-alpha | 2009 |
Attenuating effect of lisinopril and telmisartan in intracerebroventricular streptozotocin induced experimental dementia of Alzheimer's disease type: possible involvement of PPAR-γ agonistic property.
Topics: Alzheimer Disease; Animals; Benzimidazoles; Benzoates; Congo Red; Dementia; Injections, Intraventricular; Lisinopril; Maze Learning; Mice; PPAR gamma; Reaction Time; Staining and Labeling; Streptozocin; Telmisartan | 2013 |
Ameliorative effects of telmisartan on the inflammatory response and impaired spatial memory in a rat model of Alzheimer's disease incorporating additional cerebrovascular disease factors.
Topics: Alzheimer Disease; Amyloid; Angiotensin II Type 1 Receptor Blockers; Anilides; Animals; Anti-Inflammatory Agents; Benzimidazoles; Benzoates; Brain Ischemia; Cerebrovascular Disorders; Cerebrum; Disease Models, Animal; Dose-Response Relationship, Drug; Hippocampus; Inflammation; Male; Maze Learning; Memory; Memory Disorders; PPAR gamma; Rats; Rats, Wistar; Telmisartan; Tumor Necrosis Factor-alpha | 2012 |